In a "strong statements and controversies" session at the European Heart Rhythm Association (EHRA) EUROPACE-CARDIOSTIM 2017 meeting, Prof Gerhard Hindricks (University of Leipzig, Germany) said ...
The trial, called Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT), found that radiofrequency (RF) ablation guided by electroanatomic mapping of the ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...
The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...
Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...
NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
ATLANTA--(BUSINESS WIRE)--Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will present findings today at HRX 2024. The two studies showcase how Vektor’s advanced ...
(MENAFN- AETOSWire) (BUSINESS WIRE )-- Imricor Medical Systems, Inc. ( Company or Imricor) ( ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback